These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 9607565

  • 1. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
    Bunn PA, Kelly K.
    Clin Cancer Res; 1998 May; 4(5):1087-100. PubMed ID: 9607565
    [Abstract] [Full Text] [Related]

  • 2. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.
    Health Technol Assess; 2001 May; 5(32):1-195. PubMed ID: 12065068
    [Abstract] [Full Text] [Related]

  • 3. Rationale for non-platinum chemotherapy in advanced NSCLC.
    Murren JR.
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
    [Abstract] [Full Text] [Related]

  • 4. Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.
    Meert AP, Berghmans T, Branle F, Lemaître F, Mascaux C, Rubesova E, Vermylen P, Paesmans M, Sculier JP.
    Anticancer Res; 1999 Jul; 19(5C):4379-90. PubMed ID: 10650780
    [Abstract] [Full Text] [Related]

  • 5. Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer.
    Tumolo S, Toffoli G, Saracchini S, Lo Re G, Bruschi G, Boccieri MG.
    Lung Cancer; 2001 Dec; 34 Suppl 4():S37-46. PubMed ID: 11742701
    [Abstract] [Full Text] [Related]

  • 6. Radiosensitization with chemotherapeutic agents.
    Caffo O.
    Lung Cancer; 2001 Dec; 34 Suppl 4():S81-90. PubMed ID: 11742709
    [Abstract] [Full Text] [Related]

  • 7. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
    Clegg A, Scott DA, Hewitson P, Sidhu M, Waugh N.
    Thorax; 2002 Jan; 57(1):20-8. PubMed ID: 11809985
    [Abstract] [Full Text] [Related]

  • 8. New chemotherapy agents for small cell lung cancer.
    Kelly K.
    Chest; 2000 Apr; 117(4 Suppl 1):156S-162S. PubMed ID: 10777472
    [Abstract] [Full Text] [Related]

  • 9. The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE).
    Waters JS, O'Brien ME.
    Br J Cancer; 2002 Aug 27; 87(5):481-90. PubMed ID: 12189541
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapy for non-small cell lung cancer: have we reached a new plateau?
    Shepherd FA.
    Semin Oncol; 1999 Feb 27; 26(1 Suppl 4):3-11. PubMed ID: 10201515
    [Abstract] [Full Text] [Related]

  • 11. [Developed new agents for lung cancer].
    Kato Y, Saijo N.
    Nihon Geka Gakkai Zasshi; 2002 Feb 27; 103(2):218-23. PubMed ID: 11904983
    [Abstract] [Full Text] [Related]

  • 12. Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan.
    Rigas JR.
    Semin Oncol; 2001 Jun 27; 28(3 Suppl 9):15-20. PubMed ID: 11441410
    [Abstract] [Full Text] [Related]

  • 13. Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference?
    Ferrigno D, Buccheri G.
    Lung Cancer; 2000 Aug 27; 29(2):91-104. PubMed ID: 10963840
    [Abstract] [Full Text] [Related]

  • 14. Chemoradiation in locally advanced non-small cell lung cancer.
    Bonomi P, Shirazi W.
    Cancer Treat Res; 2001 Aug 27; 105():171-88. PubMed ID: 11224987
    [No Abstract] [Full Text] [Related]

  • 15. New chemotherapeutic agents for non-small cell lung cancer.
    Miller VA, Rigas JR, Grant SC, Pisters KM, Kris MG.
    Chest; 1995 Jun 27; 107(6 Suppl):306S-311S. PubMed ID: 7781411
    [Abstract] [Full Text] [Related]

  • 16. Promising new agents in the treatment of non-small cell lung cancer.
    Edelman MJ, Gandara DR.
    Cancer Chemother Pharmacol; 1996 Jun 27; 37(5):385-93. PubMed ID: 8599859
    [Abstract] [Full Text] [Related]

  • 17. Docetaxel (Taxotere) in combination chemotherapy and in association with thoracic radiotherapy for the treatment of non-small-cell lung cancer. Thoracic Oncology Program.
    Ornstein DL, Nervi AM, Rigas JR.
    Ann Oncol; 1999 Jun 27; 10 Suppl 5():S35-40. PubMed ID: 10582137
    [Abstract] [Full Text] [Related]

  • 18. The role of new agents in advanced non-small-cell lung carcinoma.
    Langer CJ.
    Curr Oncol Rep; 2000 Jan 27; 2(1):76-89. PubMed ID: 11122828
    [Abstract] [Full Text] [Related]

  • 19. [Outpatient chemotherapy for lung cancer].
    Yoneda S.
    Gan To Kagaku Ryoho; 2007 Apr 27; 34(4):533-7. PubMed ID: 17431337
    [Abstract] [Full Text] [Related]

  • 20. Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer.
    Bunn PA.
    Semin Oncol; 1999 Feb 27; 26(1 Suppl 4):25-30. PubMed ID: 10201518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.